Pauline M. Rudd

Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans

Updates to the Symbol Nomenclature for Glycans guidelines

The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines

Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity

Dengue Virus Glycosylation: What Do We Know?

Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs

The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data

The minimum information required for a glycomics experiment (MIRAGE) project: sample preparation guidelines for reliable reporting of glycomics datasets

Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis

Symbol Nomenclature for Graphical Representations of Glycans

Inactivation of GDP‐fucose transporter gene (<i>Slc35c1</i>) in CHO cells by ZFNs, TALENs and CRISPR‐Cas9 for production of fucose‐free antibodies

Biosimilarity Versus Manufacturing Change: Two Distinct Concepts

MIRAGE: The minimum information required for a glycomics experiment

Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1

Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers

EndoS2 is a unique and conserved enzyme of serotype M49 group A <i>Streptococcus</i> that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein

Increase in Sialylation and Branching in the Mouse Serum N-glycome Correlates with Inflammation and Ovarian Tumour Progression